The study of the intercellular trafficking of the fusion proteins of herpes simplex virus protein VP22

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Xue, Xiaodong ^a   Huang, Jianhua ^b   Wang, Huishan ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b Ningxia People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD34 ANTIGEN; CD45 ANTIGEN; EGFP VP22 PROTEIN; HBCL XL VP22 PROTEIN; HERMES ANTIGEN; HYBRID PROTEIN; PROTEIN VP22; THY 1 ANTIGEN; UNCLASSIFIED DRUG; VP22 EGFP PROTEIN; VP22 HBCL XL PROTEIN; VP22 MYC PROTEIN; BIOLOGICAL MARKER; BROXURIDINE; CELL EXTRACT; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; HERPES SIMPLEX VIRUS TYPE 1 PROTEIN VP22; PROTEIN BCL X; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL TRANSPORT; COCULTURE; CONTROLLED STUDY; COS 1 CELL LINE; FLOW CYTOMETRY; HERPES SIMPLEX VIRUS 1; IMMUNOFLUORESCENCE TEST; INTERCELLULAR TRANSPORT; MESENCHYMAL STEM CELL; NONHUMAN; PLASMID; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; WESTERN BLOTTING; ANIMAL; BONE MARROW CELL; CELL FRACTIONATION; CELL SEPARATION; CHLOROCEBUS AETHIOPS; CYTOLOGY; EXTRACELLULAR SPACE; HELA CELL LINE; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; PROTEIN TRANSPORT; SOLUBILITY; SPRAGUE DAWLEY RAT;

ANIMALS; BCL-X PROTEIN; BIOLOGICAL MARKERS; BONE MARROW CELLS; BROMODEOXYURIDINE; CELL EXTRACTS; CELL FRACTIONATION; CELL SEPARATION; CERCOPITHECUS AETHIOPS; COS CELLS; EXTRACELLULAR SPACE; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; PROTEIN TRANSPORT; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; SOLUBILITY; VIRAL STRUCTURAL PROTEINS;

EID: 84903524577     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100840     Document Type: Article

References (49)

1. Min JY, Yang Y, Sullivan MF, Ke Q, Converso KL, et al (2003) Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 125: p. 361-369. (Pubitemid 36228314)
2. Leri A, Kajstura J, Anversa P (2005) Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 85: p. 1373-1416. (Pubitemid 41362274)
3. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD (1996) Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98: p. 2512-2523. (Pubitemid 26415072)
4. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, et al (1998) Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4: p. 929-933. (Pubitemid 28364032)
5. Menasché P, Hagège AA, Vilquin JT, Desnos M, Abergel E, et al (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: p. 1078-1083. (Pubitemid 36384891)
6. Li RK, Jia ZQ, Weisel RD, Merante F, Mickle DA (1999) Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol 31: p. 513-522. (Pubitemid 29121638)
7. Yoo KJ, Li RK, Weisel RD, Mickle DA, Li G, et al (2000) Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann Thorac Surg 70: p. 859-865.
8. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, et al (1999) Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100: p. II247-II256. (Pubitemid 29523543)
9. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, et al (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: p. 430-436. (Pubitemid 32298545)
10. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: p. 143-147. (Pubitemid 29282067)
11. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, et al (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: p. 1195-1201. (Pubitemid 37173705)
12. Pittenger MF, Martin BJ (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95: p. 9-20. (Pubitemid 38931831)
13. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, et al (1995) Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 92: p. 4857-4861.
14. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, et al (1999) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279: p. 1528-1530. (Pubitemid 28217075)
15. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, et al (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: p. 697-705. (Pubitemid 29122423)
16. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: p. 93-98. (Pubitemid 34049148)
17. Chen J, Li Y, Wang L, Lu M, Zhang X, et al (2001) Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 189: p. 49-57. (Pubitemid 32776649)
18. Pontikoglou C, Deschaseaux F, Sensebé L, Papadaki HA (2011) Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev 7: p. 569-589.
19. Sorrell JM, Baber MA, Caplan AI (2009) Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A 15: p. 1751-1761.
20. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31: p. 890-896. (Pubitemid 37211373)
21. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, et al (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102: p. 3837-3844. (Pubitemid 37409409)
22. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, et al (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361: p. 45-46. (Pubitemid 36050962)
23. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, et al (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: p. 141-148. (Pubitemid 38891685)
24. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, et al (2001) Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33: p. 907-921. (Pubitemid 32545326)
25. Fan L, Lin C, Zhuo S, Chen L, Liu N, et al (2009) Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction. Eur J Heart Fail 11: p. 1023-1030.
26. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, et al (2005) Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46: p. 1339-1350. (Pubitemid 41615559)
27. Piao W, Wang H, Inoue M, Hasegawa M, Hamada H, et al (2010) Transplantation of Sendai viral angiopoietin-1-modified mesenchymal stem cells for ischemic limb disease. Angiogenesis 13: p. 203-210.
28. Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, et al (2007) Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25: p. 2118-2127. (Pubitemid 47258191)
29. Nienhuis AW, Dunbar CE, Sorrentino BP (2006) Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther 13(6): p. 1031-49. (Pubitemid 43779188)
30. McMahon JM, Conroy S, Lyons M, Greiser U, O'shea C, et al (2006) Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev 15(1): p. 87-96.
31. Edelstein ML, Abedi MR, Wixon J (2007) Gene therapy clinical trials worldwide to 2007-an update. J Gene Med 9(10): p. 833-42. (Pubitemid 47543250)
32. Kumar S, Chanda D, Ponnazhagan S (2008) Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther 15(10): p. 711-5. (Pubitemid 351627354)
33. Griffin M, Greiser U, Barry F, O'Brien T, Ritter T (2010) Genetically modified mesenchymal stem cells and their clinical potential in acute cardiovascular disease. Discov Med 9(46): p. 219-23.
34. Aslan H, Zilberman Y, Arbeli V, Sheyn D, Matan Y, et al (2006) Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng 12(4): p. 877-89. (Pubitemid 43726529)
35. Jo J, Nagaya N, Miyahara Y, Kataoka M, Harada-Shiba M, et al (2007) Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran. Tissue Eng 13(2): p. 313-22.
36. Helledie T, Nurcombe V, Cool SM (2008) A simple and reliable electroporation method for human bone marrow mesenchymal stem cells. Stem Cells Dev 17(4): p. 837-48.
37. Boura JS, Santos FD, Gimble JM, Cardoso CM, Madeira C, et al (2013) Direct head-to-head comparison of cationic liposome-mediated gene delivery to mesenchymal stem/stromal cells of different human sources: a comprehensive study. Hum Gene Ther Methods 24(1): p. 38-48.
38. Elliott G, O'Hare P (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88: p. 223-233. (Pubitemid 28015871)
39. Phelan A, Elliott G, O'Hare P (1998) Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotechnol 16: p. 440-443. (Pubitemid 28211195)
40. Tang T, Hammond HK (2007) Cell-based GATA4 cardiac gene transfer using cell-penetrating peptide. Circ Res 100: p. 1540-1542. (Pubitemid 46897256)
41. Lemken ML, Wolf C, Wybranietz WA, Schmidt U, Smirnow I, et al (2007) Evidence for intercellular trafficking of VP22 in living cells. Mol Ther 15: p. 310-319. (Pubitemid 46111881)
42. Nishikawa M, Otsuki T, Ota A, Guan X, Takemoto S, et al (2010) Induction of tumor-specific immune response by gene transfer of Hsp70-cell-penetrating peptide fusion protein to tumors in mice. Mol Ther 18: p. 421-428.
43. Nishi K, Saigo K (2007) Cellular internalization of green fluorescent protein fused with herpes simplex virus protein VP22 via a lipid raft-mediated endocytic pathway independent of caveolae and Rho family GTPases but dependent on dynamin and Arf6. J Biol Chem 282: p. 27503-27517. (Pubitemid 47501955)
44. Reed JC (1998) Bcl-2 family proteins. Oncogene 17: p. 3225-3236.
45. Huang J, Ito Y, Morikawa M, Uchida H, Kobune M, et al (2003) Bcl-xL gene transfer protects the heart against ischemia/reperfusion injury. Biochem Biophys Res Commun 311: p. 64-70. (Pubitemid 37297889)
46. Huang J, Nakamura K, Ito Y, Uzuka T, Morikawa M, et al (2005) Bcl-xL gene transfer inhibits Bax translocation and prolongs cardiac cold preservation time in rats. Circulation 112: p. 76-83. (Pubitemid 40962572)
47. Liang X, Chow B, Babiuk LA (1997) Study of immunogenicity and virulence of bovine herpesvirus 1 mutants deficient in the UL49 homolog, UL49.5 homolog and dUTPase genes in cattle. Vaccine 15(10): p. 1057-64. (Pubitemid 27357187)
48. Lennon DP, Caplan AI (2006) Isolation of rat marrow-derived mesenchymal stem cells. Exp Hematol 34: p. 1606-1607. (Pubitemid 44548125)
49. Rutjes SA, Bosma PJ, Rohn JL, Noteborn MH, Wesseling JG (2003) Induction of insolubility by herpes simplex virus VP22 precludes intercellular trafficking of N-terminal Apoptin-VP22 fusion proteins. J Mol Med (Berl) 81: p. 558-565. (Pubitemid 37214994)